Navigation Links
The First Ever Transplantation World-Wide of Entire Arms at the "Klinikum rechts der Isar" in Munich
Date:8/1/2008

MUNICH, August 1 /PRNewswire/ -- On the 25th/26th of July the first ever transplantation of entire arms was performed at the "Klinikum rechts der Isar" of the Technical University of Munich. The responsibility for the operation lay with the Clinic for Plastic Surgery and Hand Surgery. The operation, performed by a team of approx. 40 people, was headed by PD Dr. Christoph Hohnke (senior physician for Plastic Surgery and Hand Surgery) and Prof. Edgar Biemer (former head of Plastic Surgery Department).

In a working accident six years ago, both of the 54-year old farmer's arms were severed at the upper arms. He contacted the Clinic for Plastic Surgery and Hand Surgery at the "Klinikum rechts der Isar". The clinic's doctors are very experienced in the fields of microsurgery and replantation surgery and in the interdisciplinary preparation and planning of operations as well. Furthermore, the clinic's the Centre for Liver, Kidney and Pancreas Transplantations has intensive know-how in the field of immunosuppression.

PD Dr. Christoph Hohnke and Prof. Edgar Biemer, have been concerning themselves intensively for years both clinically and scientifically with all questions relating to transplantation and microsurgery.

A donor was found on July 25 th at around 10p.m. Christoph Hohnke began operating simultaneously with 2 teams in 2 operating theatres. One group on the left and right sides of both donor and recipient, and another team that removed a leg vein from the donor.

Both the 15-hour long operation and the first few days thereafter were ideal from the patient's point of view. His condition is excellent, considering the circumstances.

Press contact:

Tanja Schmidhofer

Klinikum rechts der Isar of the Technical University of Munich

Ismaningerstr. 22

81675 Munich

Germany

Tel.: +49-89-4402046

Fax: +49-89-4407709

Email: schmidhofer@lrz.tum.de


'/>"/>
SOURCE Klinikum rechts der Isar der Technischen Universitaet
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):